Mers

COVID-19 vaccines: Could a single vaccine work against SARS, MERS, other coronaviruses?

Researchers are working on prototypes of a so-called 'pancoronavirus vaccines' with promising, but early, results from experiments on animals.

Prenatal exposures to COVID-19 even without maternal infection will affect future generations, claims study

The researchers point out that contracting the COVID-19 infection during pregnancy can affect fetal and postnatal development negatively, as many other viral infections have previously shown to do.

Study shows similarities in host-viral interactions in SARS, MERS and COVID-19 viruses, suggests common drug treatment

Since the three viruses belong to the same family, experts believe they may share some vulnerabilities which could be exploited to treat the diseases caused by these viruses

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients

Favipiravir is an antiviral drug which was developed by a Japanese pharma company, Fujifilm Toyama Chemical, to treat influenza.

Antibodies acquired after coronavirus infection won't be effective for very long: Study

The results offer a strong note of caution against the idea of 'immunity certificates' for people who have recovered from COVID-19.

What makes coronavirus an 'ace' at invading cells? Blame its club-shaped protein spike and a molecule in the human body

In the months since the coronavirus stormed on to the world’s stage, millions have been infected and billions of other lives affected indirectly

Coronavirus Outbreak: Researchers look hopefully at Llamas' antibodies to give us a COVID-19 vaccine

Llamas’ antibodies are also easily manipulated and can be fused with other antibodies, including human's, and remain stable.

Coronavirus Outbreak: Governments knew a pandemic was a threat – here's why they weren't better prepared

Every country needs to understand and learn from how others are analysing, planning and have dealt with similar emergencies in the past.

Unregulated use of plasma therapy for COVID-19 can be harmful, writes expert; can expose patients to serious transfusion-related risks

It is a promising solution at the present gloomy situation, but till we have reliable evidence on utility unregulated use is to be avoided

Phase 3 results on Gilead coronavirus drug encouraging; a look at other potential COVID-19 treatments under trial

California-based biotech company Gilead Sciences and the US government reported that in a major study, remdesivir shortened the time it takes for COVID-19 patients to recover by four days on average